Alessandro Lugli
Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study.
Frei A, Oberson R, Baumann E, Perren A, Grobholz R, Lugli A, Dawson H, Abbet C, Lertxundi I, Reinhard S, Mookhoek A, Feichtinger J, Sarro R, Gadient G, Dommann-Scherrer C, Barizzi J, Berezowska S, Glatz K, Dertinger S, Banz Y, Schönegg R, Rubbia-Brandt L, Fleischmann A, Saile G, Mainil-Varlet P, Biral R, Giudici L, Soltermann A, Chaubert A, Stadlmann S, Diebold J, Egervari K, Bénière C, Saro F, Janowczyk A, Zlobec I. Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study. Mod Pathol 2023; 36:100335.
Sep 22, 2023Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study.
Sep 22, 2023Mod Pathol 2023; 36:100335
Frei Ana Leni, Oberson Raphaël, Baumann Elias, Perren Aurel, Grobholz Rainer, Lugli Alessandro, Dawson Heather, Abbet Christian, Lertxundi Ibai, Reinhard Stefan, Mookhoek Aart, Feichtinger Johann, Sarro Rossella, Gadient Gallus, Dommann-Scherrer Corina, Barizzi Jessica, Berezowska Sabina, Glatz Katharina, Dertinger Susanne, Banz Yara, Schönegg René, Rubbia-Brandt Laura, Fleischmann Achim, Saile Guenter, Mainil-Varlet Pierre, Biral Ruggero, Giudici Luca, Soltermann Alex, Chaubert Audrey Baur, Stadlmann Sylvia, Diebold Joachim, Egervari Kristof, Bénière Charles, Saro Francesca, Janowczyk Andrew, Zlobec Inti
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
Nesti C, Bräutigam K, Benavent M, Bernal L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot G, Camara M, Christ E, Clerici T, Clift A, Clouston H, Cobianchi L, Ćwikła J, Daskalakis K, Frilling A, Garcia-Carbonero R, Grozinsky-Glasberg S, Hernando J, Hervieu V, Hofland J, Holmager P, Inzani F, Jann H, Jimenez-Fonseca P, Kaçmaz E, Kaemmerer D, Kaltsas G, Klimacek B, Knigge U, Kolasińska-Ćwikła A, Kolb W, Kos-Kudła B, Kunze C, Landolfi S, La Rosa S, López C, Lorenz K, Matter M, Mazal P, Mestre-Alagarda C, Del Burgo P, van Dijkum E, Oleinikov K, Orci L, Panzuto F, Pavel M, Perrier M, Reims H, Rindi G, Rinke A, Rinzivillo M, Sagaert X, Satiroglu I, Selberherr A, Siebenhüner A, Tesselaar M, Thalhammer M, Thiis-Evensen E, Toumpanakis C, Vandamme T, van den Berg J, Vanoli A, van Velthuysen M, Verslype C, Vorburger S, Lugli A, Ramage J, Zwahlen M, Perren A, Kaderli R. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study. Lancet Oncol 2023; 24:187-194-194.
Jan 11, 2023Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
Jan 11, 2023Lancet Oncol 2023; 24:187-194-194
Nesti Cédric, Bräutigam Konstantin, Benavent Marta, Bernal Laura, Boharoon Hessa, Botling Johan, Bouroumeau Antonin, Brcic Iva, Brunner Maximilian, Cadiot Guillaume, Camara Maria, Christ Emanuel, Clerici Thomas, Clift Ashley K, Clouston Hamish, Cobianchi Lorenzo, Ćwikła Jarosław B, Daskalakis Kosmas, Frilling Andrea, Garcia-Carbonero Rocio, Grozinsky-Glasberg Simona, Hernando Jorge, Hervieu Valérie, Hofland Johannes, Holmager Pernille, Inzani Frediano, Jann Henning, Jimenez-Fonseca Paula, Kaçmaz Enes, Kaemmerer Daniel, Kaltsas Gregory, Klimacek Branislav, Knigge Ulrich, Kolasińska-Ćwikła Agnieszka, Kolb Walter, Kos-Kudła Beata, Kunze Catarina Alisa, Landolfi Stefania, La Rosa Stefano, López Carlos López, Lorenz Kerstin, Matter Maurice, Mazal Peter, Mestre-Alagarda Claudia, Del Burgo Patricia Morales, van Dijkum Els J M Nieveen, Oleinikov Kira, Orci Lorenzo A, Panzuto Francesco, Pavel Marianne, Perrier Marine, Reims Henrik Mikael, Rindi Guido, Rinke Anja, Rinzivillo Maria, Sagaert Xavier, Satiroglu Ilker, Selberherr Andreas, Siebenhüner Alexander R, Tesselaar Margot E T, Thalhammer Michael J, Thiis-Evensen Espen, Toumpanakis Christos, Vandamme Timon, van den Berg José G, Vanoli Alessandro, van Velthuysen Marie-Louise F, Verslype Chris, Vorburger Stephan A, Lugli Alessandro, Ramage John, Zwahlen Marcel, Perren Aurel, Kaderli Reto
Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Kienle D, Andrieu C, Bernhard J, Lugli A, Baertschi D, Helbling D, Saletti P, Kueng M, Bastian S, Horber D, Koeberle D, Winterhalder R, Quagliata L, Wicki A, Ribi K, Dietrich D, von Moos R. Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. J Geriatr Oncol 2018; 10:304-310.
Dec 14, 2018Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
Dec 14, 2018J Geriatr Oncol 2018; 10:304-310
Kienle Dirk L, Andrieu Christiane, Bernhard Juerg, Lugli Alessandro, Baertschi Daniela, Helbling Daniel, Saletti Piercarlo, Kueng Marc, Bastian Sara, Horber Daniel, Koeberle Dieter, Winterhalder Ralph C, Quagliata Luca, Wicki Andreas, Ribi Karin, Dietrich Daniel, von Moos Roger
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Lugli A, Terracciano L, Spagnoli G, Carafa V, Tornillo L, Mele V, Muraro M, Hostettler I, Iezzi G, Zlobec I. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 2010; 103:382-90.
Jul 6, 2010Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Jul 6, 2010Br J Cancer 2010; 103:382-90
Lugli Alessandro, Terracciano L, Spagnoli G, Carafa Vincenza, Tornillo Luigi, Mele V, Muraro M G, Hostettler Isabel, Iezzi Giandomenica, Zlobec Inti
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
Hostettler I, Zlobec I, Terracciano L, Lugli A. ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. World J Gastroenterol 2010; 16:732-9.
Feb 14, 2010ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
Feb 14, 2010World J Gastroenterol 2010; 16:732-9
Hostettler Isabel, Zlobec Inti, Terracciano Luigi, Lugli Alessandro
Natürliche Chromoendoskopie
Sawatzki M, Beglinger C, Lugli A, Manz M. Natürliche Chromoendoskopie. Schweiz Med Forum 2010; 10:139.
Jan 1, 2010Natürliche Chromoendoskopie
Jan 1, 2010Schweiz Med Forum 2010; 10:139
Sawatzki Mikael, Beglinger Christoph, Lugli Alessandro, Manz Michael
Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia
Lugli A, Tichelli A, Von Juergensonn S, Mach-Pascual S, Borisch B, Tinguely M, Hawle H, Korte W, Hess U, Passweg J, Gratwohl A, Cogliatti S, Ebnoether M, Dirnhofer S. Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia. Hum Pathol 2005; 36:91-100.
Jan 1, 2005Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia
Jan 1, 2005Hum Pathol 2005; 36:91-100
Lugli Alessandro, Tichelli André, Von Juergensonn Silke, Mach-Pascual Sara, Borisch Bettina, Tinguely Marianne, Hawle Hanne, Korte Wolfgang, Hess Urs, Passweg Jakob, Gratwohl Alois, Cogliatti Sergio B., Ebnoether Monika, Dirnhofer Stephan